EC Number |
Inhibitors |
Structure |
---|
1.3.99.5 | (10bR)-8-chloro-4,10b-dimethyl-1,4,6,10b-tetrahydrobenzo[f]quinoline-3(2H)-thione |
13.2% inhibition at 0.04 mM |
|
1.3.99.5 | (10bR)-8-chloro-4,10b-dimethyl-1,5,6,10b-tetrahydrophenanthridin-3(2H)-one |
- |
|
1.3.99.5 | (10bR)-8-chloro-4,5,10b-trimethyl-1,5,6,10b-tetrahydrophenanthridin-3(2H)-one |
- |
|
1.3.99.5 | (10bR)-8-chloro-5,10b-dimethyl-1,5,6,10b-tetrahydrophenanthridin-3(2H)-one |
- |
|
1.3.99.5 | (11aR)-7-(1-hydroxypropan-2-yl)-1,4a,6a-trimethylhexadecahydro-2H-indeno[5,4-f]quinolin-2-one |
weak inhibition; weak inhibition |
|
1.3.99.5 | (11aR)-7-(1-hydroxypropan-2-yl)-1,4a,6a-trimethyltetradecahydrocyclopenta[5,6]naphtho[2,1-d][1,3]oxazin-2(1H)-one |
weak inhibition; weak inhibition |
|
1.3.99.5 | (11aR)-7-(1-hydroxypropan-2-yl)-1,4a,6a-trimethyltetradecahydrocyclopenta[5,6]naphtho[2,1-d][1,3]oxazine-2(1H)-thione |
weak inhibition; weak inhibition |
|
1.3.99.5 | (11aR)-N,N-diethyl-1,4a,6a-trimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide |
weak inhibition; weak inhibition |
|
1.3.99.5 | (16alpha,17beta)-17-hydroxy-16-methylandrost-4-en-3-one |
- |
|
1.3.99.5 | (16beta)-16-bromo-3,20-dioxopregna-1,4,6-trien-17-yl cyclopentylacetate |
- |
|